Headlines from the Proactive UK newsroom.
Polarean Imaging (LON:POLX) has received positive results from Phase III Clinical Trials of its lung scanning technology. Both trials met their primary endpoints. An application for US approval will be made in the autumn.
Internet domain name specialist Minds + Machines (LON:MMX) will pay a maiden dividend with its next full year results. Sales last year were significantly ahead of 2018 with renewal revenue accounting for 60% of the total.
Ergomed (LON:ERGO) has also seen strong trading with underlying profits ahead of market expectations. Both its clinical research organisation and pharmacovigilance businesses traded well with order books healthy going into 2020.
Apple posted 11% higher profits and a better than expected 8% rise in sales in the Christmas quarter as iPhone sales were higher than forecast. Apple added it is "closely monitoring" the coronavirus situation in China and has widened its sales forecast for this quarter due to the outbreak.
British Airways, meanwhile, has suspended bookings for direct flights from London to Beijing and Shanghai until March. UK travellers have been advised to avoid all but essential travel to China due to the coronavirus.
Plus, Ovo Energy has been fined £8.9mln by the energy regulator for overcharging customers and issuing inaccurate information. Ovo recently paid £500mln to acquire the retail business of big six energy group SSE.